Embecta (EMBC) Total Current Liabilities (2021 - 2026)
Embecta (EMBC) posted Total Current Liabilities of $247.3 million for Q1 2026, up 5.37% sequentially from $234.7 million in Q4 2025, and down 4.63% YoY from $259.3 million in Q1 2025.
Embecta (EMBC) Total Current Liabilities (2021 - 2026) Analysis & Trends
Embecta has reported Total Current Liabilities for 6 years, with the latest figure at $247.3 million in Q1 2026.
- Quarterly Total Current Liabilities fell 4.63% year-over-year to $247.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $247.3 million (down 4.63% YoY) and the FY2025 annual result came in at $261.5 million, down 30.08% from the prior year.
- Total Current Liabilities grew to $247.3 million in Q1 2026 per EMBC's latest filing, from $234.7 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $385.8 million in Q2 2023 and troughed at $168.9 million in Q1 2022.
- A 5-year average of $301.4 million and a median of $301.0 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities jumped 132.75% in 2022, then slumped 30.08% in 2025.
- Over 5 years, Total Current Liabilities stood at $370.3 million in 2022, then declined by 11.8% to $326.6 million in 2023, then fell by 8.7% to $298.2 million in 2024, then fell by 21.29% to $234.7 million in 2025, then gained by 5.37% to $247.3 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $247.3 million, $234.7 million, and $261.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 419.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 419.80 Mn |
| Mar 31, 2026 | 247.30 Mn |
| Dec 31, 2025 | 234.70 Mn |
| Sep 30, 2025 | 261.50 Mn |
| Jun 30, 2025 | 275.50 Mn |
| Mar 31, 2025 | 259.30 Mn |
| Dec 31, 2024 | 298.20 Mn |
| Sep 30, 2024 | 374.00 Mn |
| Jun 30, 2024 | 370.70 Mn |
| Mar 31, 2024 | 310.40 Mn |
| Dec 31, 2023 | 326.60 Mn |
| Sep 30, 2023 | 353.50 Mn |
| Jun 30, 2023 | 385.80 Mn |
| Mar 31, 2023 | 357.70 Mn |
| Dec 31, 2022 | 370.30 Mn |
| Sep 30, 2022 | 301.00 Mn |
| Jun 30, 2022 | 228.50 Mn |
| Mar 31, 2022 | 168.90 Mn |
| Dec 31, 2021 | 159.10 Mn |
| Sep 30, 2021 | 164.00 Mn |